Sort
30,917 grants matching “tumor microenvironment”
Spatially precise radio-chemo-immunotherapy using antibody conjugates
$506,426Sunil J Advani · University Of California, San Diego · R01 · FY2024 · CA
Improving response durability after CAR T cell therapy for multiple myeloma
$506,376Michael C. Milone · University Of Pennsylvania · P01 · FY2023 · CA
Controlling cancer with aspirin-triggered stimulation of resolution
$506,329Dipak Panigrahy · Beth Israel Deaconess Medical Center · R01 · FY2015 · CA
Regulation of ovarian cancer metastasis by microenvironment-induced chromatin accessibility and c-Jun activation.
$506,309Anirban Kumar Mitra · Indiana University Indianapolis · R01 · FY2025 · CA
Aerosol Delivery of Topotecan for Personalized Lung Cancer Therapy
$506,214Mathewos Tessema · Lovelace Biomedical & Environmental Research Institute · R01 · FY2016 · CA
Role of metalloproteinases in mammary gland remodeling
$506,174Zena Werb · University Of California, San Francisco · R01 · FY2012 · CA
Tumor matrix remodeling in anti-myeloma immunity and immunotherapy
$506,049Fotios Asimakopoulos · University Of California, San Diego · R01 · FY2022 · CA
Tumor matrix remodeling in anti-myeloma immunity and immunotherapy
$506,049Fotios Asimakopoulos · University Of California, San Diego · R01 · FY2023 · CA
Nanocage-based systemic delivery of TGFβ trap for immunomodulation of brain neoplasms
$505,973Jung Soo Suk · Johns Hopkins University · R01 · FY2022 · NS
Molecular, Genetic and Cellular Targets of Cancer Training Program
$505,869Scott M. Dehm · University Of Minnesota · T32 · FY2025 · CA
The Immunomodulatory Function of Cyclin E1 in Ovarian Cancer and Therapeutic Targeting
$505,851Liya Ding · Roswell Park Cancer Institute Corp · R37 · FY2024 · CA
The Immunomodulatory Function of Cyclin E1 in Ovarian Cancer and Therapeutic Targeting
$505,851Liya Ding · Roswell Park Cancer Institute Corp · R37 · FY2025 · CA
Nanocage-based systemic delivery of TGFβ trap for immunomodulation of brain neoplasms
$505,850Jung Soo Suk · Johns Hopkins University · R01 · FY2023 · NS
Dissecting the NRG4 hormonal checkpoint in metabolic liver disease
$505,838Jiandie D Lin · University Of Michigan At Ann Arbor · R01 · FY2020 · DK
TOPAS - nBio, a Monte Carlo tool for radiation biology research
$505,751Jan Patrick Oscar Schuemann · Massachusetts General Hospital · R01 · FY2022 · CA
Tumor microenvironment: Impact on T cell tumor-targeting, activation and survival
$505,733Ronald G Blasberg · Sloan-Kettering Inst Can Research · R01 · FY2015 · CA
Localized immunotherapy using alum-binding therapeutics
$505,710Darrell J Irvine · Massachusetts Institute Of Technology · R01 · FY2024 · EB
Vascular regulation of fatty acid transport in metastatic tumor outgrowth
$505,681Jin Chen · Vanderbilt University Medical Center · R01 · FY2025 · CA
Vascular regulation of fatty acid transport in metastatic tumor outgrowth
$505,681Jin Chen · Vanderbilt University Medical Center · R01 · FY2023 · CA
Novel Approaches to Targeting Cancers Associated with VHL Mutations
$505,669Ramaprasad Srinivasan · Division Of Basic Sciences - Nci · ZIA · FY2020 · CA
Project 3: Immune Response to PDT
$505,665Sandra O Gollnick · Roswell Park Cancer Institute Corp · P01 · FY2019 · CA
Differential TGF-Beta Signaling in Bone Microenviroment: Impact on Tumor Growth
$505,665Theresa A Guise · Indiana University Indianapolis · U01 · FY2013 · CA
EBNA1 Inhibitor for Treatment of EBV-positive DLBCL
$505,631Paul M. Lieberman · Wistar Institute · R01 · FY2024 · CA
Statistical Methods for Precision Prevention
$505,613Li Hsu · Fred Hutchinson Cancer Center · R01 · FY2025 · CA
Project 3: Immune Response to PDT
$505,551Sandra O Gollnick · Roswell Park Cancer Institute Corp · P01 · FY2015 · CA